Vasantha Malladi
About Vasantha Malladi
Vasantha Malladi is the Senior Director of Solid Tumor Portfolio Strategy & Governance at BeiGene, with over 16 years of experience in the biopharmaceutical industry.
Current Position at BeiGene
Vasantha Malladi is currently working as the Senior Director of Solid Tumor Portfolio Strategy & Governance at BeiGene, located in New Jersey, United States. In this role, Vasantha focuses on strategy and governance within the company's solid tumor portfolio. With over 16 years of experience in the biopharmaceutical industry, Vasantha brings a wealth of expertise to her position, ensuring the effective management and expansion of BeiGene's solid tumor initiatives.
Previous Experience at Bristol-Myers Squibb
Prior to joining BeiGene, Vasantha Malladi held the position of Director, Integrated Strategy, WW Hematology at Bristol-Myers Squibb from 2020 to 2023. Located in Summit, New Jersey, she led the portfolio strategy for the hematology oncology franchise. Vasantha's role involved strategic planning and management, contributing significantly to the global hematology strategy within the company.
Role at Celgene
Vasantha Malladi served as the Associate Director of Global Market Insights, Early Commercialization at Celgene from 2018 to 2020. During her tenure at Celgene, located in Summit, New Jersey, Vasantha provided early-stage commercialization insights that were critical to the company's market strategies. Her work involved deep therapeutic area knowledge and a strong understanding of commercial opportunities and risks.
Educational Background
Vasantha Malladi has an extensive academic background in the field of life sciences. She holds a PhD from the University of Leicester and Anna University Chennai, where she studied cell biology, molecular biology, and microbiology. Additionally, she earned an MSc in Biochemistry and a BSc in Chemistry from the University of Madras. Vasantha completed her high school education at Jawahar Vidyalaya.
Career in Consulting
Vasantha Malladi has significant experience in consulting, having worked across various roles at Cello Health BioConsulting (Previously Defined Health) and Deallus. She started as an Associate Consultant in 2007 and eventually became a Senior Consultant by 2015, before moving to Deallus as a Senior Manager. These roles emphasized her ability to manage teams, grow key client accounts, and lead strategy projects for pharmaceutical, biotechnology, and investment firms.